P
Pierre-Emmanuel Bonnot
Researcher at University of Lyon
Publications - 11
Citations - 357
Pierre-Emmanuel Bonnot is an academic researcher from University of Lyon. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Cancer. The author has an hindex of 5, co-authored 9 publications receiving 160 citations.
Papers
More filters
Journal ArticleDOI
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.
Pierre-Emmanuel Bonnot,Guillaume Piessen,Vahan Kepenekian,Evelyne Decullier,Marc Pocard,Bernard Meunier,J.M. Bereder,Karine Abboud,Frédéric Marchal,François Quenet,Diane Goéré,Simon Msika,Catherine Arvieux,Nicolas Pirro,Romuald Wernert,Patrick Rat,Johan Gagnière,Jérémie H. Lefevre,Thomas Courvoisier,Reza Kianmanesh,Delphine Vaudoyer,Michel Rivoire,Pierre Meeus,Guillaume Passot,Olivier Glehen,Fregat,Big-Renape Networks +26 more
TL;DR: Compared with CRSa, CRS-HIPEC improved OS and recurrence-free survival, without additional morbidity or mortality, and may be considered a valuable therapy for strictly selected patients with limited PMs from GC.
Journal ArticleDOI
Improved Peritoneal Cavity and Abdominal Organ Imaging Using a Biphasic Contrast Agent Protocol and Spectral Photon Counting Computed Tomography K-Edge Imaging.
Salim Si-Mohamed,Arnaud Thivolet,Pierre-Emmanuel Bonnot,Daniel Bar-Ness,Vahan Kepenekian,David P. Cormode,Philippe Douek,Pascal Rousset +7 more
TL;DR: Spectral photon-counting CT can be used to perform a complete peritoneal dual-contrast protocol, enabling a good assessment of the peritoneAL cavity and abdominal organs in rats.
Journal ArticleDOI
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
Mohammad Alyami,Pierre-Emmanuel Bonnot,Frederic Mercier,Nathalie Laplace,Laurent Villeneuve,Guillaume Passot,Naoual Bakrin,Vahan Kepenekian,Olivier Glehen +8 more
TL;DR: PIPAC with low-dose cisplatin and doxorubicin is safe and feasible in association with systemic chemotherapy for gastric PM and justify further clinical studies in this indication.
Journal ArticleDOI
Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Mohammad Alyami,Frederic Mercier,Matthieu Siebert,Pierre-Emmanuel Bonnot,Nathalie Laplace,Laurent Villeneuve,Guillaume Passot,Olivier Glehen,Naoual Bakrin,Vahan Kepenekian +9 more
TL;DR: Complete CRS and HIPEC can be achieved in strictly selected patient with unresectable PM at diagnosis after repeated PIPAC session with palliative intent, as described in this study.
Journal ArticleDOI
Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
Pierre-Emmanuel Bonnot,A Lintis,Frederic Mercier,Nazim Benzerdjeb,Guillaume Passot,Marc Pocard,Bernard Meunier,J.M. Bereder,Karine Abboud,Frédéric Marchal,François Quenet,Diane Goéré,Simon Msika,Catherine Arvieux,Nicolas Pirro,Romuald Wernert,P. Rat,Johan Gagnière,Jérémie H. Lefevre,Thomas Courvoisier,Reza Kianmanesh,Delphine Vaudoyer,Michel Rivoire,Pierre Meeus,Laurent Villeneuve,Guillaume Piessen,Olivier Glehen,Fregat,Big-Renape Networks +28 more
TL;DR: In this article, the impact of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on the prognosis of gastric poorly cohesive carcinoma (PCC) was investigated.